Cargando…
P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430847/ http://dx.doi.org/10.1097/01.HS9.0000846608.67535.a5 |
| _version_ | 1784779888730832896 |
|---|---|
| author | Einsele, H. Moreau, P. Delforge, M. van de Donk, N. W. Ghilotti, F. Diels, J. Elsada, A. Strulev, V. Pei, L. Kobos, R. Smit, J. Slavcev, M. Weisel, K. Mateos, M.-V. |
| author_facet | Einsele, H. Moreau, P. Delforge, M. van de Donk, N. W. Ghilotti, F. Diels, J. Elsada, A. Strulev, V. Pei, L. Kobos, R. Smit, J. Slavcev, M. Weisel, K. Mateos, M.-V. |
| author_sort | Einsele, H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430847 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94308472022-08-31 P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY Einsele, H. Moreau, P. Delforge, M. van de Donk, N. W. Ghilotti, F. Diels, J. Elsada, A. Strulev, V. Pei, L. Kobos, R. Smit, J. Slavcev, M. Weisel, K. Mateos, M.-V. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430847/ http://dx.doi.org/10.1097/01.HS9.0000846608.67535.a5 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Einsele, H. Moreau, P. Delforge, M. van de Donk, N. W. Ghilotti, F. Diels, J. Elsada, A. Strulev, V. Pei, L. Kobos, R. Smit, J. Slavcev, M. Weisel, K. Mateos, M.-V. P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY |
| title | P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY |
| title_full | P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY |
| title_fullStr | P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY |
| title_full_unstemmed | P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY |
| title_short | P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE LOCOMOTION STUDY |
| title_sort | p935: real world comparative analysis of the efficacy of teclistamab versus current treatments in patients with triple-class exposed relapsed/refractory multiple myeloma from the locomotion study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430847/ http://dx.doi.org/10.1097/01.HS9.0000846608.67535.a5 |
| work_keys_str_mv | AT einseleh p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy AT moreaup p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy AT delforgem p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy AT vandedonknw p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy AT ghilottif p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy AT dielsj p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy AT elsadaa p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy AT strulevv p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy AT peil p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy AT kobosr p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy AT smitj p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy AT slavcevm p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy AT weiselk p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy AT mateosmv p935realworldcomparativeanalysisoftheefficacyofteclistamabversuscurrenttreatmentsinpatientswithtripleclassexposedrelapsedrefractorymultiplemyelomafromthelocomotionstudy |